This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
BZAM Overzicht aandelen
Operates as a cannabis producer with a focus on branded consumer goods.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 0/6 |
BZAM Ltd. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | CA$0.025 |
| 52 Week Hoogtepunt | CA$0.21 |
| 52 Week Laag | CA$0.01 |
| Bèta | 2.69 |
| 11 maand verandering | 0% |
| 3 maanden verandering | 0% |
| 1 Jaar Verandering | -84.85% |
| 33 jaar verandering | -99.19% |
| 5 jaar verandering | -99.93% |
| Verandering sinds IPO | -99.94% |
Recent nieuws en updates
Market Cool On BZAM Ltd.'s (CSE:BZAM) Revenues Pushing Shares 36% Lower
Apr 16
Not Many Are Piling Into BZAM Ltd. (CSE:BZAM) Just Yet
Feb 10Recent updates
Market Cool On BZAM Ltd.'s (CSE:BZAM) Revenues Pushing Shares 36% Lower
Apr 16Not Many Are Piling Into BZAM Ltd. (CSE:BZAM) Just Yet
Feb 10BZAM Ltd. (CSE:BZAM) Might Not Be As Mispriced As It Looks After Plunging 26%
Oct 24Is Green Organic Dutchman Holdings (TSE:TGOD) Using Too Much Debt?
Aug 17Auditors Are Concerned About Green Organic Dutchman Holdings (TSE:TGOD)
Mar 13Things Look Grim For The Green Organic Dutchman Holdings Ltd. (TSE:TGOD) After Today's Downgrade
Mar 12Green Organic Dutchman Holdings' (TSE:TGOD) Stock Price Has Reduced 65% In The Past Year
Dec 16Rendement voor aandeelhouders
| BZAM | CA Pharmaceuticals | CA Markt | |
|---|---|---|---|
| 7D | 0% | -1.8% | 0.4% |
| 1Y | -84.8% | -6.7% | 24.6% |
Rendement versus industrie: BZAM underperformed the Canadian Pharmaceuticals industry which returned 26.8% over the past year.
Rendement versus markt: BZAM underperformed the Canadian Market which returned 9.5% over the past year.
Prijsvolatiliteit
| BZAM volatility | |
|---|---|
| BZAM Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.4% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Stabiele aandelenkoers: BZAM's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: Insufficient data to determine BZAM's volatility change over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Matt Milich | bzam.com |
BZAM Ltd. Samenvatting
| BZAM fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | CA$6.77m |
| Inkomsten(TTM) | -CA$105.54m |
| Inkomsten(TTM) | CA$81.65m |
0.1x
P/S-verhouding-0.1x
Koers/WinstverhoudingIs BZAM overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| BZAM resultatenrekening (TTM) | |
|---|---|
| Inkomsten | CA$81.65m |
| Kosten van inkomsten | CA$54.29m |
| Brutowinst | CA$27.36m |
| Overige uitgaven | CA$132.90m |
| Inkomsten | -CA$105.54m |
Laatst gerapporteerde inkomsten
Sep 30, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.39 |
| Brutomarge | 33.51% |
| Nettowinstmarge | -129.25% |
| Schuld/Eigen Vermogen Verhouding | 42.5% |
Hoe presteerde BZAM op de lange termijn?
Bekijk historische prestaties en vergelijking